Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-02

FDA Approved: ESCITALOPRAM OXALATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approves an original application for escitalopram oxalate as a generic drug, manufactured by Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram Oxalate (escitalopram oxalate)

Snippet

ORIG AP for ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)